Home > Riviste > Minerva Cardioangiologica > Fascicoli precedenti > Minerva Cardioangiologica 2014 Ottobre;62(5) > Minerva Cardioangiologica 2014 Ottobre;62(5):421-6

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA CARDIOANGIOLOGICA

Rivista sulle Malattie del Cuore e dei Vasi


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

REVIEW  


Minerva Cardioangiologica 2014 Ottobre;62(5):421-6

lingua: Inglese

Polymer-free amphilimus-eluting stents in patients with diabetes mellitus

Romaguera R., Gómez-Lara J., Jacobi F., Gomez-Hospital J. A., Cequier A.

Heart Diseases Institute, Hospital de Bellvitge‑IDIBELL, University of Barcelona, Barcelona, Spain


PDF  


Despite several improvements in drug-eluting stents design, diabetes mellitus (DM) remains an Achilles’ heel for percutaneous coronary revascularization at the present time. The Cre8 stent is a third-generation drug-eluting stent devoid of polymer. The drug, which is formulated with an amphiphilic carrier, is eluted from laser-dug wells on the stent’s abluminal surface. The Cre8 stent hat has shown promising preliminary results in patients with DM. This review summarizes the mechanisms of DES failure in patients with DM and the potential role of the Cre8 stent in this high-risk population.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

rafaromaguera@gmail.com